coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    High Weald PCN, Wealden · Health Inequalities Profile

    PCN U54760 · NHS Surrey and Sussex Integrated Care Board; NHS Sussex Integrated Care Board · 7 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    55,868

    Registered population

    54.8% aged 18–64

    27.3%

    Aged 65+

    ICB 21.9% · England 17.9%

    4.2%

    Ethnic minority (non-White)

    1.4% Asian · England 9.6%

    0.0%

    In IMD quintile 1

    ICB 9.2% · England 21.0%

    0

    Core20 residents (est.)

    Resident basis; registered basis 0 · see page 3

    9,599

    Hypertension register

    +4.97% in 3 yrs · England +5.60%

    493

    SMI register

    30.4% of Wealden's

    976

    COPD register

    Reviews +1.18% in 3 yrs

    Forecast to 2030

    11,062

    Hypertension patients, 2030

    +1,463 on today

    61.2%

    QRISK ≥20% on statins, 2030

    +3.52pp over 3 yrs

    5.5%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    71.7%
    Hypertension blood pressure control exceeds comparators.

    Treatment to target reached 71.7% (Wealden 70.0%, ICB 69.1%, England 70.3%) after a +16.3% three-year change (England +3.6%).

    53.4%
    Lipid therapy in high-risk patients lags.

    Only 53.4% of QRISK ≥ 20% patients receive lipid therapy (England 63.6%), and 65+ prescribing is 6,929 per 1,000 (England 18,056).

    -18.9%
    Learning disability register fell over three years.

    Recorded prevalence fell 18.9% over 2023 to 2025 (England +5.4%), leaving 296 registered patients and a benchmark scenario gap of +9 to +32.

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Patients aged 65 and over comprise 27.3% of the list, exceeding England's 17.9%

    High Weald PCN serves 55,868 registered patients across seven practices. Patients aged 65 and over account for 27.3% of the list (15,247 patients), above Wealden (25.3%), NHS Sussex Integrated Care Board (21.9%), and England (17.9%). Patients aged 18–64 represent 54.8% and those aged 0–17 account for 17.9%. Based on Census resident data, 95.8% identify as White (Wealden 96.0%, NHS Sussex Integrated Care Board 91.0%, England 81.1%) and 4.2% non-White. Census ethnicity reflects resident catchment populations rather than registered patients.

    Age profile

    0–1717.9%
    18–6454.8%
    65+27.3%

    65+: ICB 21.9%, England 17.9%

    Ethnicity

    White95.8%
    Mixed1.9%
    Asian1.4%
    Other0.5%
    Black0.5%

    Older people · falls rows are Wealden local-authority (LA) data, not PCN

    MeasureLocalSouth EastEnglandPeriod
    Falls admissions, 65+, per 100,000 (Wealden LA)2,2462,0181,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)88.3%82.2%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)65.8%57.8%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Wealden LA)9589819552024/25
    Falls deaths, all ages, per 100,000 (Wealden LA)8.614.014.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Average IMD decile is 7.8 with 0.0% of registered patients in Core20 areas

    Average IMD decile is 7.8 for the PCN, above Wealden (7.1), NHS Sussex Integrated Care Board (6.1) and England (5.5). In national Core20 areas, 0.0% of registered patients reside, compared with 1.7% in Wealden, 9.2% in NHS Sussex Integrated Care Board and 21.0% in England, with 0 of 41 associated LSOAs in national deciles 1 or 2. Across the network, all seven practices record a 0.0% Core20 share (0 estimated patients). Practice average IMD deciles range from 6.7 at Wadhurst Medical Group to 8.4 at Saxonbury House Surgery.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Beacon0.0% · 0 patients
    Ashdown Forest0.0% · 0 patients
    Wadhurst Medical0.0% · 0 patients
    Woodhill0.0% · 0 patients
    Rotherfield0.0% · 0 patients
    Saxonbury House0.0% · 0 patients
    Groombridge And0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    493

    SMI register

    0.88% recorded prevalence

    296

    Learning disability register

    0.53% recorded prevalence

    24

    Care homes, 907 beds

    In the PCN catchment

    8.8%

    Provide unpaid care

    Wealden, Census 2021

    High Weald PCN records 493 patients on its severe mental illness register (0.9%) and 296 on its learning disability register (0.5%), representing 30.4% and 30.1% of Wealden's borough totals. The PCN catchment includes 24 care homes with 907 beds. In Wealden, 10 rough sleepers were recorded in the autumn 2025 snapshot, and the borough unpaid carer rate of 8.8% gives a ceiling estimate of 4,916 carers.

    Severe mental illness: physical health checks

    SMI checks show 88.7% had blood pressure monitored and 90.5% had BMI recorded, exceeding England (83.4% and 82.1%). Smoking cessation offers for patients with certain conditions fell 0.8 pp over 2023 to 2025 (England +0.1 pp).

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    9,599

    Hypertension register

    +4.97%

    Register growth, 3 yrs

    Wealden +5.15% · England +5.60%

    +12.33pp

    BP control, under 80

    ≤140/90 · +6.29pp aged 80+

    +1,463

    More patients by 2030

    Forecast 11,062 (18.86%)

    Hypertension case-finding and control

    High Weald PCN records 9,599 patients on its hypertension register (17.1% prevalence, against 17.7% in Wealden, 16.3% in NHS Sussex Integrated Care Board, and 15.2% in England). Recent blood pressure monitoring reached 91.6% (England 90.0%). Treatment to target reached 71.7% (England 70.3%), rising +16.3% over 2023 to 2025 (England +3.6%). Under-80 control reached 70.2% (England 67.8%), whereas control in patients aged 80 and over trailed at 79.2% (England 81.2%). Crude prevalence is not age-adjusted. Above-average overall blood pressure control contrasts with lower control in patients aged 80 and over.

    Lipids and statins

    Patients with QRISK ≥ 20% receiving lipid-lowering therapy reached 53.4%, trailing England (63.6%), Wealden (56.8%), and NHS Sussex Integrated Care Board (60.0%). CKD lipid therapy also lags at 62.4% against England's 70.3%. Fewer high-risk patients receive lipid-lowering therapy than comparator benchmarks indicate.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 2026105,639£2.20£2.42£1.86£232,406
    Cardiovascular (all), 2025142,266£3.21£3.32£3.33£456,674

    In 2026, High Weald PCN prescribed 105,639 lipid-regulating drug items at £2.20 per item, compared with £1.86 in England and £2.42 in NHS Sussex Integrated Care Board. Across these items, the PCN spent £35,917 more than at England's unit cost. Prescribing unit costs exceed England, which could reflect formulary choices, testable by review.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    −2.52%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +2.50%

    Asthma prevalence, PCN 3-yr % change

    Asthma reviews fell 2.5% over 2023 to 2025 to 61.9% (England +4.4% to 65.7%), leaving a scale indicator of 1,390 of 3,648 register patients unreviewed. Second-hand smoke recording for asthma patients aged 6-19 was 74.3% (England 78.8%), and youth asthma prescribing was 1,312 items per 1,000 (England 1,488). COPD prevalence is 1.7% (England 1.9%) with 74.0% reviewed (England 76.4%). Lower reviews could reflect recall or access differences, testable by clinical audit.

    Cancer register and children's immunisation

    Cancer prevalence is 5.2% (2,918 patients; England 3.8%). In Q1 2025/26, age-5 4-in-1 booster coverage was 82.8% and MMR dose 2 was 85.9%, sitting below the 95.0% target by 12.2 pp and 9.1 pp respectively, with a 3.2 pp drop between MMR dose 1 (89.1%) and dose 2. Across captured practices, QOF vaccination achievement spans 70.9 pp, which could reflect recall variation, testable by practice audit.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months90.7%

    England 91.0%

    6-in-1 complete primary course at 24 months90.6%

    England 92.2%

    MMR dose 1 at 24 months88.7%

    England 88.3%

    MMR dose 2 at age 585.9%

    England 82.8%

    4-in-1 pre-school booster at age 582.8%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    58.5%

    Sussex ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~1,360

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Sussex ICBEnglandNo usable stageStaged cancers
    Prostate56.6%53.2%19%1,668
    Breast86.1%85.4%23%1,400
    Bowel49.8%47.0%26%1,133
    Lung30.3%33.8%15%1,058
    Skin cancer95.3%87.8%17%698

    In NHS Sussex ICB, 58.5% of cancers with a known stage were diagnosed at stage 1 or 2 in 2022 (4,799 of 8,209 staged cancers), 16.5 pp below the 75.0% national ambition by 2028, requiring about 1,360 extra early diagnoses annually; known-stage completeness was 64.3% (8,209 of 12,766 registered cases). Locally, High Weald PCN breast screening coverage fell 14.6% over 2023 to 2024 to 69.8% (England +8.4% to 69.9%), while cervical screening rose +1.5% over 2023 to 2025 to 72.8% (England -1.0%). Slower PCN cancer register growth (+3.2% vs England +9.0%) could reflect recording or referral differences, unverified locally and testable by practice audit.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In July 2026 (provisional), Maidstone and Tunbridge Wells NHS Trust achieved 87.4% on the cancer 62-day referral to treatment standard (219 of 250.5 pathways), exceeding the 85.0% standard by 2.4 pp. This surpassed Surrey and Sussex Healthcare NHS Trust (70.0%), University Hospitals Sussex NHS Foundation Trust (65.2%), NHS Surrey and Sussex Integrated Care Board (71.5%) and England (71.2%). The trust also met the 28-day faster diagnosis standard at 81.8% (1,759 of 2,151 pathways; target 75.0%), above England (79.3%). Across NHS Surrey and Sussex Integrated Care Board, 62-day performance was 71.5%, remaining 13.5 pp below standard.

    Pathways within standard (%)Maidstone and Tunbridge WellsSussexSurrey and Sussex HealthcareSurrey and Sussex ICBEngland
    28-day faster diagnosis (75%)81.7874.0177.7479.2979.32
    31-day treatment (96%)98.3576.7996.2090.4592.50
    62-day referral to treatment (85%)87.4365.2069.9771.5171.16
    Diagnostic waits over 6 weeks (%)Maidstone and Tunbridge WellsSussexSurrey and Sussex HealthcareEngland
    MRI0.925.6227.5321.40
    CT0.518.5718.499.92
    Echocardiography2.570.3943.7828.48
    Colonoscopy19.8039.3515.1130.83
    Gastroscopy24.0320.0221.0629.02
    All 15 DM01 tests6.4212.9528.5023.14
    Community services activityEast Sussex residentsSurrey and Sussex ICB
    Care contacts100,740309,615
    Referrals17,28566,930
    Patients with a contact25,88085,660

    Community services (residents of East Sussex), Jun 2026 (provisional). In June 2026 (provisional), community services recorded 100,740 contacts with Wealden residents, of which 68,465 were with adults aged 65 and over, representing a 68% share. This concentration of community contacts among older residents aligns with the local age profile, although these data describe borough residents rather than PCN-level activity.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Practice phone access spans 68.0 pp while vaccination achievement spans 70.9 pp

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Groombridge And1200.093.0%82.5%98.7%
    Woodhill Surgery1260.088.5%79.3%91.1%
    Beacon Surgery1140.064.3%79.9%89.9%
    Ashdown Forest1140.059.6%78.3%83.2%
    Saxonbury House1020.025.0%56.8%70.2%
    Rotherfield1000.035.9%75.6%66.1%
    Wadhurst Medical900.028.5%66.6%65.8%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNWealdenAssetPCNWealden
    Care homes (catchment)24 (907 beds)n/aSchools (catchment)68n/a
    Children's centresno data2Places of worship87161
    Libraries17Food banks (VCS)n/a1
    Homelessness support (VCS)02Day centres (VCS)n/a6
    Children and young people (VCS)n/a1Carers support groups (VCS)n/a1
    Primary schools (LA maintained)2340Primary academies48

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    High-risk lipid therapy recall review

    QRISK ≥ 20% lipid therapy is 53.4% (Wealden 56.8%, ICB 60.0%, England 63.6%), CKD lipid therapy is 62.4% (England 70.3%), and 65+ prescribing is 6,929 per 1,000 (England 18,056). Moderate effort to run.

    Evidence base: delivery measure for eight care processes and three treatment targets; shortfall here is what shows up later as emergency admission.

    Policy anchor: NHS Diabetes Prevention Programme and the eight care processes / three treatment targets.

    Option 2

    Structured annual asthma review recall

    Asthma reviews fell 2.5% over 2023 to 2025 to 61.9% (Wealden 63.5%, ICB 62.5%, England 65.7%), leaving a scale indicator of 1,390 of 3,648 register patients unreviewed. For discussion: the PCN could introduce a single asthma review template, align inhaler checks, and offer flexible review slots across practices. Low cost, quick to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 3

    Learning disability register coding validation

    Learning disability prevalence is 0.5% (296 patients, 30.1% of Wealden's register; England 0.6%), falling 18.9% over 2023 to 2025 (England +5.4%), with a benchmark gap of +9 to +32 patients. For discussion: practices could audit historical learning disability diagnostic codes and cross-check registers with social-care records where agreements exist. Low cost, quick to run.

    Evidence base: the register is the cohort for the annual health check and LeDeR learning; people with a learning disability die on average 20 years earlier and are a Core20PLUS5 PLUS group.

    Policy anchor: annual health checks for 75% of people aged 14+ on the register (Network Contract DES); Oliver McGowan mandatory training.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Smoking cessation offer audit (p4)Smoking cessation support and treatment offered to patients with certain conditions (denominator incl. PCAs)MHIS · From Harm to HopePCN
    Older hypertensive cohort review (p5)Last BP reading of patients (80+ yrs with hypertension) in the last 12 months is <= 150/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school immunisation call and recall (p6)4-in-1 pre-school booster (DTaP/IPV) coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cancer register diagnostic coding audit (p7)Cancer: QOF prevalenceCore20PLUS5, 75% stage 1–2 by 2028PCN
    Practice telephony and triage review (p9)GPPS easy to contact the practice by phone10YHP, hospital to communityPractice
    Option 1 · High-risk lipid therapy recall review (p12)Patients with QRISK ≥ 20% treated with lipid lowering therapy · CKD patients treated with lipid lowering therapy · Patients with diabetes (40+ yrs no history of CVD) treated with a statin (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Option 2 · Structured annual asthma review recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) · Patients with Asthma (6-19 yrs): Second-hand smoking status recorded in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN
    Option 3 · Learning disability register coding validation (p12)Learning disability register · Learning disability: QOF prevalence75% annual health checks (Network Contract DES) · Oliver McGowanPCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026ICB2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15